Company: MDCXW
Filing Date: 2025-04-04
Form Type: POS AM
Source: 0001062993-25-007073
Chunk: 222

Company: Medicus Pharma Ltd.
Filing Date: 2025-04-04
Form: POS AM
Chunk 222
---
 by reference from Exhibit 24.1 to the Registrant's Registration Statement on Form F-1, filed with the SEC on July 15, 2024)                                                                                                       |
| 107         | Filing fee table                                                                                                                                                                                                                                                   |

____________________________

*Filed herewith.

+Indicates a management contract or compensatory plan.

#Schedules and certain other private or confidential information (as indicated therein) have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The Company hereby undertakes to furnish supplementally copies of any of the omitted schedules upon request by the SEC.

† Certain private or confidential information (as indicated therein) have been redacted pursuant to Item 601(a)(6) of Regulation S-K.

<div align='center'>II-6

SIGNATURES</div>

Pursuant to the requirements of the Securities Act, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized in W. Conshohocken, Pennsylvania on this 4 day of April, 2025.

| MEDICUS PHARMA LTD. |                                                       |
| By:                 | /s/ Raza Bokhari                                      |
|                     | Name: Dr. Raza Bokhari                                
 Title: Executive Chairman and Chief Executive Officer |

<div align='center'>II-7</div>

Pursuant to the requirements of the Securities Act, this registration statement has been signed by the following persons in the capacities and on the dates indicated below.

| Signature               
 /s/ Raza Bokhari        |     | Title                                                          
 Executive Chairman and Chief Executive Officer                 
 (Principal Executive Officer)                                  |     | Date          
 April 4, 2025 |
|:------------------------|:----|:---------------------------------------------------------------|:----|:--------------|
| Dr. Raza Bokhari        |     |                                                                |     |               |
| /s/ James Quinlan       |     | Chief Financial Officer                                        
 (Principal Financial Officer and Principal Accounting Officer) |     | April 4, 2025 |
| James Quinlan           |     |                                                                |     |               |
| *                       |     | Director                                                       |     | April 4, 2025 |
| Dr. Larry Kaiser        |     |                                                                |     |               |
| *                       |     | Director                                                       |     | April 4, 2025 |
| Robert J. Ciaruffoli    |     |